Intended Research Use Delivers 20-24% weight loss in 48 weeks Shreds visceral fat and fixes liver issues (82% reduction) Drops HbA1c ~2%, improves all metabolic markers Burns calories like exercise through glucagon activation menu_bookScientific Publications N Engl J Med (2023) Triplehormone-receptor agonist retatrutide for obesitya phase 2 trial open_in_new Lancet (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes open_in_new Nat Med (2024) Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease open_in_new Maximum Value: The 20mg vial provides the best value per mg for aggressive weight loss protocols
Metformin continuation or discontinuation: Some providers continue metformin for its modest additional benefit and low cost
Although Ozempic shares an active ingredient with some medications used for weight loss, its approval is strictly for diabetes management, and not for weight loss due to the need for regular in-person lab monitoring and glucose management
The main role of this drug for diabetes treatment is to tell the body to make more insulin, which then reduces blood sugar
Rights and permissions About this article Cite this article Martel, J., Ojcius, D., Chang, CJ
